Assistance Publique - Hôpitaux de Paris: Cognitive Dysfunction trials
The registry lists 14 Cognitive Dysfunction studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 3 1No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)Not yet recruitingNCT07081464
- A Clinical Decision Support Tool for Assessing the Ability to Decide on Returning Home in Elderly Patients with Cognitive ImpairmentsNot yet recruitingNCT06669559Not applicable
- Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-ADRecruitingNCT06582199Not applicable
- Association Between Cognitive Impairment and the Presence of Hearing Problems and Precarious ConditionsNot yet recruitingNCT06478888
- Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer PatientsNot yet recruitingNCT05754060
- Deafness and Cognition in Middle-aged AdultsRecruitingNCT05149742Not applicable
- The Montreal Cognitive Assessment.Test in Adults With Sickle Cell DiseaseCompletedNCT05347043Not applicable
- NEUROFEEDBACK TRAINING FOR OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT: A PILOT STUDYWithdrawnNCT04027725Not applicable
- The Effect of the Glycemic Variability on Macular Retinal Microcirculation and Cognitive Functions in Patient With Type 1 DiabetesCompletedNCT03821753
- Cerebrovascular Reactivity in Alzheimer's DiseaseCompletedNCT03650816
- Ketamine and Postoperative Cognitive DysfunctionCompletedNCT02892916Phase 3
- New Biomarker for Alzheimer's Disease DiagnosticCompletedNCT01315639Not applicable
- Early Cognitive Impairment in Multiple SclerosisCompletedNCT01157728
- System-IGF-1 Pathway and Alzheimer's DiseaseCompletedNCT00647478